ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody Drug CDMO Service Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-9O18473
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antibody Drug CDMO Service Market Research Report 2024
BUY CHAPTERS

Global Antibody Drug CDMO Service Market Research Report 2024

Code: QYRE-Auto-9O18473
Report
October 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Abzena
AGC Biologics
Axplora
Batavia Biosciences
Chemexpress
Fujifilm
GTP Bioways
HALIX
Mycenax
Wuxi Biologics
ProBio
Samsung Biologics
Sigma-aldrich

Antibody Drug CDMO Service Market

Antibody Drug CDMO Service (Contract Development and Manufacturing Organization) refers to a business model that provides full-chain services from R&D to production for antibody drugs. This service model covers all stages of antibody drug R&D, including preclinical research, clinical research and commercial production, and aims to help pharmaceutical companies accelerate the R&D process of antibody drugs, improve production efficiency and reduce production costs through professional technical capabilities and production facilities.
The global Antibody Drug CDMO Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Antibody Drug CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antibody Drug CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antibody Drug CDMO Service in Antibody Drug Conjugates is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antibody Drug CDMO Service include Abzena, AGC Biologics, Axplora, Batavia Biosciences, ChemExpress, FUJIFILM, GTP Bioways, Halix, MYCENAX, WuXi Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antibody Drug CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug CDMO Service.
The Antibody Drug CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Drug CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Drug CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antibody Drug CDMO Service Market Report

Report Metric Details
Report Name Antibody Drug CDMO Service Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abzena, AGC Biologics, Axplora, Batavia Biosciences, ChemExpress, FUJIFILM, GTP Bioways, Halix, MYCENAX, WuXi Biologics, ProBio, Samsung Biologics, Sigma-Aldrich
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antibody Drug CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibody Drug CDMO Service Market report?

Ans: The main players in the Antibody Drug CDMO Service Market are Abzena, AGC Biologics, Axplora, Batavia Biosciences, ChemExpress, FUJIFILM, GTP Bioways, Halix, MYCENAX, WuXi Biologics, ProBio, Samsung Biologics, Sigma-Aldrich

What are the Application segmentation covered in the Antibody Drug CDMO Service Market report?

Ans: The Applications covered in the Antibody Drug CDMO Service Market report are Antibody Drug Conjugates, Monoclonal Antibodies, Others

What are the Type segmentation covered in the Antibody Drug CDMO Service Market report?

Ans: The Types covered in the Antibody Drug CDMO Service Market report are Customized Service, Lab-based Service, Others

Recommended Reports

CDMO Services

Biologics & Cell Therapy

Antibody/Peptide Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Drug CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Customized Service
1.2.3 Lab-based Service
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Drug CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Antibody Drug Conjugates
1.3.3 Monoclonal Antibodies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug CDMO Service Market Perspective (2019-2030)
2.2 Global Antibody Drug CDMO Service Growth Trends by Region
2.2.1 Global Antibody Drug CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Drug CDMO Service Historic Market Size by Region (2019-2024)
2.2.3 Antibody Drug CDMO Service Forecasted Market Size by Region (2025-2030)
2.3 Antibody Drug CDMO Service Market Dynamics
2.3.1 Antibody Drug CDMO Service Industry Trends
2.3.2 Antibody Drug CDMO Service Market Drivers
2.3.3 Antibody Drug CDMO Service Market Challenges
2.3.4 Antibody Drug CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Drug CDMO Service Players by Revenue
3.1.1 Global Top Antibody Drug CDMO Service Players by Revenue (2019-2024)
3.1.2 Global Antibody Drug CDMO Service Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Drug CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Drug CDMO Service Revenue
3.4 Global Antibody Drug CDMO Service Market Concentration Ratio
3.4.1 Global Antibody Drug CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug CDMO Service Revenue in 2023
3.5 Global Key Players of Antibody Drug CDMO Service Head office and Area Served
3.6 Global Key Players of Antibody Drug CDMO Service, Product and Application
3.7 Global Key Players of Antibody Drug CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug CDMO Service Breakdown Data by Type
4.1 Global Antibody Drug CDMO Service Historic Market Size by Type (2019-2024)
4.2 Global Antibody Drug CDMO Service Forecasted Market Size by Type (2025-2030)
5 Antibody Drug CDMO Service Breakdown Data by Application
5.1 Global Antibody Drug CDMO Service Historic Market Size by Application (2019-2024)
5.2 Global Antibody Drug CDMO Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Drug CDMO Service Market Size (2019-2030)
6.2 North America Antibody Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Drug CDMO Service Market Size by Country (2019-2024)
6.4 North America Antibody Drug CDMO Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Drug CDMO Service Market Size (2019-2030)
7.2 Europe Antibody Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Drug CDMO Service Market Size by Country (2019-2024)
7.4 Europe Antibody Drug CDMO Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Drug CDMO Service Market Size (2019-2030)
8.2 Asia-Pacific Antibody Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Drug CDMO Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Drug CDMO Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Drug CDMO Service Market Size (2019-2030)
9.2 Latin America Antibody Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Drug CDMO Service Market Size by Country (2019-2024)
9.4 Latin America Antibody Drug CDMO Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Drug CDMO Service Market Size (2019-2030)
10.2 Middle East & Africa Antibody Drug CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Drug CDMO Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Drug CDMO Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abzena
11.1.1 Abzena Company Details
11.1.2 Abzena Business Overview
11.1.3 Abzena Antibody Drug CDMO Service Introduction
11.1.4 Abzena Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.1.5 Abzena Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Details
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics Antibody Drug CDMO Service Introduction
11.2.4 AGC Biologics Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.2.5 AGC Biologics Recent Development
11.3 Axplora
11.3.1 Axplora Company Details
11.3.2 Axplora Business Overview
11.3.3 Axplora Antibody Drug CDMO Service Introduction
11.3.4 Axplora Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.3.5 Axplora Recent Development
11.4 Batavia Biosciences
11.4.1 Batavia Biosciences Company Details
11.4.2 Batavia Biosciences Business Overview
11.4.3 Batavia Biosciences Antibody Drug CDMO Service Introduction
11.4.4 Batavia Biosciences Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.4.5 Batavia Biosciences Recent Development
11.5 ChemExpress
11.5.1 ChemExpress Company Details
11.5.2 ChemExpress Business Overview
11.5.3 ChemExpress Antibody Drug CDMO Service Introduction
11.5.4 ChemExpress Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.5.5 ChemExpress Recent Development
11.6 FUJIFILM
11.6.1 FUJIFILM Company Details
11.6.2 FUJIFILM Business Overview
11.6.3 FUJIFILM Antibody Drug CDMO Service Introduction
11.6.4 FUJIFILM Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.6.5 FUJIFILM Recent Development
11.7 GTP Bioways
11.7.1 GTP Bioways Company Details
11.7.2 GTP Bioways Business Overview
11.7.3 GTP Bioways Antibody Drug CDMO Service Introduction
11.7.4 GTP Bioways Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.7.5 GTP Bioways Recent Development
11.8 Halix
11.8.1 Halix Company Details
11.8.2 Halix Business Overview
11.8.3 Halix Antibody Drug CDMO Service Introduction
11.8.4 Halix Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.8.5 Halix Recent Development
11.9 MYCENAX
11.9.1 MYCENAX Company Details
11.9.2 MYCENAX Business Overview
11.9.3 MYCENAX Antibody Drug CDMO Service Introduction
11.9.4 MYCENAX Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.9.5 MYCENAX Recent Development
11.10 WuXi Biologics
11.10.1 WuXi Biologics Company Details
11.10.2 WuXi Biologics Business Overview
11.10.3 WuXi Biologics Antibody Drug CDMO Service Introduction
11.10.4 WuXi Biologics Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.10.5 WuXi Biologics Recent Development
11.11 ProBio
11.11.1 ProBio Company Details
11.11.2 ProBio Business Overview
11.11.3 ProBio Antibody Drug CDMO Service Introduction
11.11.4 ProBio Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.11.5 ProBio Recent Development
11.12 Samsung Biologics
11.12.1 Samsung Biologics Company Details
11.12.2 Samsung Biologics Business Overview
11.12.3 Samsung Biologics Antibody Drug CDMO Service Introduction
11.12.4 Samsung Biologics Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.12.5 Samsung Biologics Recent Development
11.13 Sigma-Aldrich
11.13.1 Sigma-Aldrich Company Details
11.13.2 Sigma-Aldrich Business Overview
11.13.3 Sigma-Aldrich Antibody Drug CDMO Service Introduction
11.13.4 Sigma-Aldrich Revenue in Antibody Drug CDMO Service Business (2019-2024)
11.13.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Abzena
AGC Biologics
Axplora
Batavia Biosciences
Chemexpress
Fujifilm
GTP Bioways
HALIX
Mycenax
Wuxi Biologics
ProBio
Samsung Biologics
Sigma-aldrich
List of Tables
 Table 1. Global Antibody Drug CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Customized Service
 Table 3. Key Players of Lab-based Service
 Table 4. Key Players of Others
 Table 5. Global Antibody Drug CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Antibody Drug CDMO Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Antibody Drug CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Antibody Drug CDMO Service Market Share by Region (2019-2024)
 Table 9. Global Antibody Drug CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Antibody Drug CDMO Service Market Share by Region (2025-2030)
 Table 11. Antibody Drug CDMO Service Market Trends
 Table 12. Antibody Drug CDMO Service Market Drivers
 Table 13. Antibody Drug CDMO Service Market Challenges
 Table 14. Antibody Drug CDMO Service Market Restraints
 Table 15. Global Antibody Drug CDMO Service Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Antibody Drug CDMO Service Market Share by Players (2019-2024)
 Table 17. Global Top Antibody Drug CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug CDMO Service as of 2023)
 Table 18. Ranking of Global Top Antibody Drug CDMO Service Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Antibody Drug CDMO Service Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Antibody Drug CDMO Service, Headquarters and Area Served
 Table 21. Global Key Players of Antibody Drug CDMO Service, Product and Application
 Table 22. Global Key Players of Antibody Drug CDMO Service, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Antibody Drug CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Antibody Drug CDMO Service Revenue Market Share by Type (2019-2024)
 Table 26. Global Antibody Drug CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Antibody Drug CDMO Service Revenue Market Share by Type (2025-2030)
 Table 28. Global Antibody Drug CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Antibody Drug CDMO Service Revenue Market Share by Application (2019-2024)
 Table 30. Global Antibody Drug CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Antibody Drug CDMO Service Revenue Market Share by Application (2025-2030)
 Table 32. North America Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Antibody Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Antibody Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Antibody Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Antibody Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Antibody Drug CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Antibody Drug CDMO Service Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Antibody Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Antibody Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Antibody Drug CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Antibody Drug CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Antibody Drug CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Abzena Company Details
 Table 48. Abzena Business Overview
 Table 49. Abzena Antibody Drug CDMO Service Product
 Table 50. Abzena Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 51. Abzena Recent Development
 Table 52. AGC Biologics Company Details
 Table 53. AGC Biologics Business Overview
 Table 54. AGC Biologics Antibody Drug CDMO Service Product
 Table 55. AGC Biologics Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 56. AGC Biologics Recent Development
 Table 57. Axplora Company Details
 Table 58. Axplora Business Overview
 Table 59. Axplora Antibody Drug CDMO Service Product
 Table 60. Axplora Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 61. Axplora Recent Development
 Table 62. Batavia Biosciences Company Details
 Table 63. Batavia Biosciences Business Overview
 Table 64. Batavia Biosciences Antibody Drug CDMO Service Product
 Table 65. Batavia Biosciences Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 66. Batavia Biosciences Recent Development
 Table 67. ChemExpress Company Details
 Table 68. ChemExpress Business Overview
 Table 69. ChemExpress Antibody Drug CDMO Service Product
 Table 70. ChemExpress Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 71. ChemExpress Recent Development
 Table 72. FUJIFILM Company Details
 Table 73. FUJIFILM Business Overview
 Table 74. FUJIFILM Antibody Drug CDMO Service Product
 Table 75. FUJIFILM Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 76. FUJIFILM Recent Development
 Table 77. GTP Bioways Company Details
 Table 78. GTP Bioways Business Overview
 Table 79. GTP Bioways Antibody Drug CDMO Service Product
 Table 80. GTP Bioways Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 81. GTP Bioways Recent Development
 Table 82. Halix Company Details
 Table 83. Halix Business Overview
 Table 84. Halix Antibody Drug CDMO Service Product
 Table 85. Halix Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 86. Halix Recent Development
 Table 87. MYCENAX Company Details
 Table 88. MYCENAX Business Overview
 Table 89. MYCENAX Antibody Drug CDMO Service Product
 Table 90. MYCENAX Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 91. MYCENAX Recent Development
 Table 92. WuXi Biologics Company Details
 Table 93. WuXi Biologics Business Overview
 Table 94. WuXi Biologics Antibody Drug CDMO Service Product
 Table 95. WuXi Biologics Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 96. WuXi Biologics Recent Development
 Table 97. ProBio Company Details
 Table 98. ProBio Business Overview
 Table 99. ProBio Antibody Drug CDMO Service Product
 Table 100. ProBio Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 101. ProBio Recent Development
 Table 102. Samsung Biologics Company Details
 Table 103. Samsung Biologics Business Overview
 Table 104. Samsung Biologics Antibody Drug CDMO Service Product
 Table 105. Samsung Biologics Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 106. Samsung Biologics Recent Development
 Table 107. Sigma-Aldrich Company Details
 Table 108. Sigma-Aldrich Business Overview
 Table 109. Sigma-Aldrich Antibody Drug CDMO Service Product
 Table 110. Sigma-Aldrich Revenue in Antibody Drug CDMO Service Business (2019-2024) & (US$ Million)
 Table 111. Sigma-Aldrich Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Antibody Drug CDMO Service Picture
 Figure 2. Global Antibody Drug CDMO Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Antibody Drug CDMO Service Market Share by Type: 2023 VS 2030
 Figure 4. Customized Service Features
 Figure 5. Lab-based Service Features
 Figure 6. Others Features
 Figure 7. Global Antibody Drug CDMO Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Antibody Drug CDMO Service Market Share by Application: 2023 VS 2030
 Figure 9. Antibody Drug Conjugates Case Studies
 Figure 10. Monoclonal Antibodies Case Studies
 Figure 11. Others Case Studies
 Figure 12. Antibody Drug CDMO Service Report Years Considered
 Figure 13. Global Antibody Drug CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Antibody Drug CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Antibody Drug CDMO Service Market Share by Region: 2023 VS 2030
 Figure 16. Global Antibody Drug CDMO Service Market Share by Players in 2023
 Figure 17. Global Top Antibody Drug CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug CDMO Service as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Antibody Drug CDMO Service Revenue in 2023
 Figure 19. North America Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Antibody Drug CDMO Service Market Share by Country (2019-2030)
 Figure 21. United States Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Antibody Drug CDMO Service Market Share by Country (2019-2030)
 Figure 25. Germany Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Antibody Drug CDMO Service Market Share by Region (2019-2030)
 Figure 33. China Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Antibody Drug CDMO Service Market Share by Country (2019-2030)
 Figure 41. Mexico Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Antibody Drug CDMO Service Market Share by Country (2019-2030)
 Figure 45. Turkey Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Antibody Drug CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Abzena Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 49. AGC Biologics Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 50. Axplora Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 51. Batavia Biosciences Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 52. ChemExpress Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 53. FUJIFILM Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 54. GTP Bioways Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 55. Halix Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 56. MYCENAX Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 57. WuXi Biologics Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 58. ProBio Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 59. Samsung Biologics Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 60. Sigma-Aldrich Revenue Growth Rate in Antibody Drug CDMO Service Business (2019-2024)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Full Service CDMO Market Research Report 2024
Global Small Molecule Drug CDMO Services Market Research Report 2024
Global Contract Dose Manufacturing Market Insights Forecast to 2030
Global Oligonucleotide Drug CDMO Services Market Research Report 2024
Global ADC Drug CDMO Service Market Research Report 2024
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Global Biologics CDMO Services Market Research Report 2024
Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical CDMO Service Market Research Report 2024
Global Pharmaceutical CDMO Market Research Report 2025
Global Chemical CDMO Market Research Report 2024
Global Chemical Drug CDMO Market Research Report 2024
Global Small Molecules CDMO Services Market Research Report 2024
Global Biological Drug CDMO Market Research Report 2024
Global Formulation CDMO Services Market Research Report 2024
Global Biopharmaceutical CDMO Market Research Report 2025
Biologics CDMO Market
Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA CDMO Service Market Research Report 2024
Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions